Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Efficacy of a Web-Based Intervention to Increase Uptake of Maternal Vaccines: An RCT.

O'Leary ST, Narwaney KJ, Wagner NM, Kraus CR, Omer SB, Glanz JM.

Am J Prev Med. 2019 Oct;57(4):e125-e133. doi: 10.1016/j.amepre.2019.05.018. Epub 2019 Aug 27.

PMID:
31471001
2.

Addressing personal parental values in decisions about childhood vaccination: Measure development.

Cataldi JR, Sevick C, Pyrzanowski J, Wagner N, Brewer SE, Narwaney KJ, Shoup JA, Resnicow K, Glanz J, Dempsey A, Kwan BM.

Vaccine. 2019 Sep 10;37(38):5688-5697. doi: 10.1016/j.vaccine.2019.08.009. Epub 2019 Aug 14.

PMID:
31421930
3.

Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy.

Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S.

JAMA Netw Open. 2019 Apr 5;2(4):e192613. doi: 10.1001/jamanetworkopen.2019.2613.

4.

Development and evaluation of a standardized research definition for opioid overdose outcomes.

Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM.

Subst Abus. 2019;40(1):71-79. doi: 10.1080/08897077.2018.1546263. Epub 2019 Mar 15.

PMID:
30875477
5.

Social Media Vaccine Websites: A Comparative Analysis of Public and Moderated Websites.

Shoup JA, Narwaney KJ, Wagner NM, Kraus CR, Gleason KS, Albright K, Glanz JM.

Health Educ Behav. 2019 Jun;46(3):454-462. doi: 10.1177/1090198118818253. Epub 2018 Dec 29.

PMID:
30596265
6.

Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care.

Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, Breslin K, Mueller SR, Glanz JM.

Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.

7.

Addressing Parents' Vaccine Concerns: A Randomized Trial of a Social Media Intervention.

Daley MF, Narwaney KJ, Shoup JA, Wagner NM, Glanz JM.

Am J Prev Med. 2018 Jul;55(1):44-54. doi: 10.1016/j.amepre.2018.04.010. Epub 2018 May 14.

PMID:
29773490
8.

Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age.

Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O.

JAMA. 2018 Mar 6;319(9):906-913. doi: 10.1001/jama.2018.0708.

9.

Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.

Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA.

J Gen Intern Med. 2018 Oct;33(10):1646-1653. doi: 10.1007/s11606-017-4288-3. Epub 2018 Jan 29.

10.

Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial.

Glanz JM, Wagner NM, Narwaney KJ, Kraus CR, Shoup JA, Xu S, O'Leary ST, Omer SB, Gleason KS, Daley MF.

Pediatrics. 2017 Dec;140(6). pii: e20171117. doi: 10.1542/peds.2017-1117. Epub 2017 Nov 6.

11.

Vaccine adverse events in a safety net healthcare system and a managed care organization.

Narwaney KJ, Breslin K, Ross CA, Shoup JA, Wain KF, Weintraub ES, McNeil MM, Hambidge SJ.

Vaccine. 2017 Mar 1;35(9):1335-1340. doi: 10.1016/j.vaccine.2017.01.017. Epub 2017 Feb 6.

12.

Development of an interactive social media tool for parents with concerns about vaccines.

Shoup JA, Wagner NM, Kraus CR, Narwaney KJ, Goddard KS, Glanz JM.

Health Educ Behav. 2015 Jun;42(3):302-12. doi: 10.1177/1090198114557129. Epub 2014 Nov 19.

PMID:
25413375
13.

Timely versus delayed early childhood vaccination and seizures.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F.

Pediatrics. 2014 Jun;133(6):e1492-9. doi: 10.1542/peds.2013-3429.

PMID:
24843064
14.

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.

Vaccine. 2014 May 23;32(25):3019-24. doi: 10.1016/j.vaccine.2014.03.063. Epub 2014 Mar 31.

PMID:
24699471
15.

Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.

Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF.

Curr Med Res Opin. 2014 Aug;30(8):1687-99. doi: 10.1185/03007995.2014.905461. Epub 2014 Apr 7.

PMID:
24635013
16.

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.

JAMA Pediatr. 2013 Nov;167(11):1060-4. doi: 10.1001/jamapediatrics.2013.2353.

PMID:
24019039
17.

A mixed methods study of parental vaccine decision making and parent-provider trust.

Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF.

Acad Pediatr. 2013 Sep-Oct;13(5):481-8. doi: 10.1016/j.acap.2013.05.030.

18.

A population-based cohort study of undervaccination in 8 managed care organizations across the United States.

Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.

JAMA Pediatr. 2013 Mar 1;167(3):274-81. doi: 10.1001/jamapediatrics.2013.502.

PMID:
23338829
19.

Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children.

Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ.

Vaccine. 2013 Feb 4;31(7):1123-8. doi: 10.1016/j.vaccine.2012.12.026. Epub 2012 Dec 20.

PMID:
23261040
20.

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.

Greene SK, Li L, Shay DK, Fry AM, Lee GM, Jacobsen SJ, Baxter R, Irving SA, Jackson ML, Naleway AL, Nordin JD, Narwaney KJ, Lieu TA.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):335-44. doi: 10.1002/pds.3363. Epub 2012 Nov 5.

PMID:
23129321
21.

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.

Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112.

PMID:
21810637
22.

Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children.

Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ.

Vaccine. 2011 Jan 29;29(5):994-9. doi: 10.1016/j.vaccine.2010.11.085. Epub 2010 Dec 8.

Supplemental Content

Loading ...
Support Center